Role of free oxygen radicals and prostanoids in the pathogenesis of Henoch-Schönlein Purpura.
The pathogenesis of Henoch-Schonlein Purpura (HSP) is still controversial. The aim of our study was to investigate the role of oxidative stress and cyclooxygenase (CO) pathway products in the pathogenesis of HSP. In order to investigate this, malondialdehyde (MDA) levels, indicating lipid peroxidation, prostaglandin E (PGE)-like activity as inflammatory mediator and vitamin E (vit-E) levels indicating anti-oxidant status were studied in a group of 10 children with HSP (five girls and five boys, aged 6-21 years, mean 10.7 years), both in the acute and recovery phase of the disease and in five age and sex-matched healthy children as a control group. The patients were also grouped into low and high clinical score groups. Plasma levels of MDA and PGE-like activity were significantly elevated in the active phase of HSP compared to the recovery phase. Vit-E levels were significantly reduced in the active phase compared to the recovery phase. The plasma levels of PGE-like activity of the patients obtained in the active phase were significantly higher than the levels of the control group, whereas the levels of the recovery phase were significantly lower than in the control group. No such difference between the controls and MDA and vit-E levels in the patient group was shown. No correlation between the clinical scores and the parameters studied could be found. Our findings indicate that oxidant stress and CO pathway products may play a role in the pathogenesis of HSP.
Buyan
N
N
Pediatric Nephrology Department, Gazi University, Faculty of Medicine, Ankara, Turkey.
Erbaş
D
D
Akkök
N
N
Oz
E
E
Biberoğlu
G
G
Hasanoğlu
E
E
D002648:Child; D005260:Female; D006801:Humans; D011695:IgA Vasculitis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D018384:Oxidative Stress; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism*; D011458:Prostaglandins E / Q000097:blood; D017382:Reactive Oxygen Species / Q000378:metabolism*; D016896:Treatment Outcome; D014810:Vitamin E / Q000097:blood
D011453:Prostaglandins; D011458:Prostaglandins E; D017382:Reactive Oxygen Species; D014810:Vitamin E; D008315:Malondialdehyde; D011451:Prostaglandin-Endoperoxide Synthases